Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
DAWN Day One Biopharmaceuticals
12.750-0.250-1.92%
Close
03/30 16:00 ET
High
13.300
Open
12.870
Turnover
17.14M
Low
12.340
Pre Close
13.000
Volume
1.34M
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Sign in to post a comment
$Day One Biopharmaceuticals(DAWN.US$ really good firm with good data in commercialisation stage... believe this will be a future buyout candidate.
576 Views
Like
Comment
Share
$Day One Biopharmaceuticals(DAWN.US$ good data
Like
Comment
Share
Like
Comment
Share
$ChromaDex(CDXC.US$ Li Kaishing very own elixir company... Hehe
$Futu Holdings Ltd(FUTU.US$$Ginkgo Bioworks(DNA.US$$Day One Biopharmaceuticals(DAWN.US$$Alibaba(BABA.US$
$Futu Holdings Ltd(FUTU.US$$Ginkgo Bioworks(DNA.US$$Day One Biopharmaceuticals(DAWN.US$$Alibaba(BABA.US$
Like
Comment
Share
$ChromaDex(CDXC.US$ anti ageing supplements...very plausible especially when the ExxonMobil of FOOD, Nestle is working w it.
300mg — Nicotinamide Riboside | Tru Niagen
$CRISPR Therapeutics(CRSP.US$$Ginkgo Bioworks(DNA.US$ £ $Day One Biopharmaceuticals(DAWN.US$$BioNTech(BNTX.US$$Moderna(MRNA.US$
300mg — Nicotinamide Riboside | Tru Niagen
$CRISPR Therapeutics(CRSP.US$$Ginkgo Bioworks(DNA.US$ £ $Day One Biopharmaceuticals(DAWN.US$$BioNTech(BNTX.US$$Moderna(MRNA.US$
Like
Comment
Share
$Haleon(HLN.US$ this is one dip I got to scoop up...its a no brainer. The largest OTC drug maker.
$Day One Biopharmaceuticals(DAWN.US$$Viridian Therapeutics(VRDN.US$$Bristol-Myers Squibb(BMY.US$$BioNTech(BNTX.US$
$Day One Biopharmaceuticals(DAWN.US$$Viridian Therapeutics(VRDN.US$$Bristol-Myers Squibb(BMY.US$$BioNTech(BNTX.US$
+2
Like
Comment
Share
$Day One Biopharmaceuticals(DAWN.US$$WiMi Hologram Cloud(WIMI.US$$Materion(MTRN.US$ I will need to add more shares as time goes on
Like
Comment
Share
Like
Comment
Share
ColumnToday's pre-market stock movers: BNTX, JBLU, DWAC, SAVE and more
Gainers:
• $Axsome Therapeutics(AXSM.US$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics(CAPR.US$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
• $Axsome Therapeutics(AXSM.US$ +39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder)
• $Capricor Therapeutics(CAPR.US$ +4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
Like
Comment
Share
WATCHLIST 06/27 MONDAY
$Alpha Tau Medical(DRTS.US$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US$
- Co on Sunday Announced Results of Relapsed Pediatric Low-Grade Glioma Show 64% Overall Response Rate. recently added. Looking for more above $18.
$Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares(DRIP.US$
...
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US$
- Co on Sunday Announced Results of Relapsed Pediatric Low-Grade Glioma Show 64% Overall Response Rate. recently added. Looking for more above $18.
$Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares(DRIP.US$
...
Like
Comment
Share
No comment yet
